HFA Premium Access

Discontinuation and re-initiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

Congress Presentation

About the speaker

Ms Laura Landucci

Karolinska University Hospital, Stockholm (Sweden)
0 follower

6 more presentations in this session

Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and type 2 diabetes. Data from the Swedish Heart Failure Registry and National Diabetes Registry

Speaker: Doctor F. Musella (Naples, IT)

Thumbnail

Insulin therapy in patients with heart failure and type 2 diabetes: predictors of use and associations with outcomes. Data from the Swedish Heart Failure Registry and National Diabetes Registry.

Speaker: Mr M. Biber (Trieste, IT)

Thumbnail

Deciphering mortality risk of antidiabetic medications in well-treated heart failure patients with diabetes mellitus

Speaker: Assistant Professor I. Colluoglu (Karabuk, TR)

Thumbnail

Survival analysis in heart failure and end-stage chronic kidney disease: a propensity score matched study comparing peritoneal dialysis and hemodialysis

Speaker: Assistant Professor A. Sahin (Sivas, TR)

Thumbnail

Hyperkalemia consequences on the probability of interrupting or lowering renin-angiotensin-aldosterone system inhibitors and risk of hospitalization in patients with chronic cardiovascular conditions

Speaker: Doctor S. Jimenez-Marrero (Barcelona, ES)

Thumbnail

Access the full session

Treating heart failure with diabetes and renal disease

Speakers: Ms L. Landucci, Doctor F. Musella, Mr M. Biber, Assistant Professor I. Colluoglu, Assistant Professor A. Sahin...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations